<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

<address id="pfpd9"><var id="pfpd9"></var></address>
<sub id="pfpd9"><var id="pfpd9"></var></sub>

<thead id="pfpd9"><var id="pfpd9"><ins id="pfpd9"></ins></var></thead>

<address id="pfpd9"><listing id="pfpd9"></listing></address>

<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

    <thead id="pfpd9"><var id="pfpd9"><output id="pfpd9"></output></var></thead><sub id="pfpd9"><var id="pfpd9"><ins id="pfpd9"></ins></var></sub><sub id="pfpd9"></sub>
    <address id="pfpd9"></address><address id="pfpd9"></address>

    <sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

      Areas of Focus

      We concentrate our research and development efforts on our core disease areas listed below and are pursuing multiple drug platforms for these areas.

      Innovative science is our passion. Transformational medicines are our goal. Bristol-Myers Squibb is committed to discovering, developing and delivering transformational medicines in areas where we believe we have an opportunity to make a meaningful difference for patients: oncology, immunoscience, cardiovascular and fibrosis.

      Therapeutic?Areas

      Oncology

      Oncology

      Our vision for the future of cancer care is focused on researching and developing transformational oncology medicines . . .

      Triangle Icon
      Immunoscience

      Immunoscience

      Bristol-Myers Squibb is committed to developing transformational therapies that will lead to long-lasting remission?. . .

      Triangle Icon
      Cardiovascular

      Cardiovascular

      We are expanding our innovation in cardiovascular disease to focus on underserved areas with a concentration on highly validated targets . . .

      Triangle Icon
      Fibrosis

      Fibrosis

      We are researching novel medicines that have the potential to halt or reverse the progression of fibrosis, the buildup of excessive scar tissue that impairs normal organ function . . .

      Triangle Icon

      Drug Platforms

      Antibody-Drug Conjugates

      Antibody-Drug Conjugates

      By tethering a small molecule to a biologic, antibody-drug conjugates are engineered?. . .

      Triangle Icon
      Biologics

      Biologics

      Biologics are large molecules produced from living organisms . . .

      Triangle Icon
      Drug Delivery Technology

      Drug Delivery Technology

      Novel technologies that will safely and effectively deliver?. . .

      Triangle Icon
      Gene Therapy

      Gene Therapy

      Gene therapy delivers modified DNA to correct, repair or replace a defective disease-causing gene?. . .

      Triangle Icon
      Millamolecules

      Millamolecules

      Millamolecules are mid-range compounds that fall in size between small molecules and biologics?. . .

      Triangle Icon
      RNA Oligonucleotides

      RNA Oligonucleotides

      Short strands of nucleic acids synthesized?. . .

      Triangle Icon
      Small Molecules

      Small Molecules

      These are organic compounds that are relatively small in size?. . .

      Triangle Icon
      日本最新免费一区